Literature DB >> 18377959

The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells.

Sanjeev K Sahni1, Elena Rydkina, Abha Sahni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18377959     DOI： 10.1016/j.thromres.2008.01.011

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

1.  Transcriptional Upregulation of Plasminogen Activator Inhibitor-1 in Rat Primary Astrocytes by a Proteasomal Inhibitor MG132.

Authors:  Kyu Suk Cho; Kyoung Ja Kwon; Se Jin Jeon; So Hyun Joo; Ki Chan Kim; Jae Hoon Cheong; Geon Ho Bahn; Hahn Young Kim; Seol Heui Han; Chan Young Shin; Sung-Il Yang
Journal:  Biomol Ther (Seoul)       Date:  2013-03       Impact factor: 4.634

2.  The MLN4924 inhibitor exerts a neuroprotective effect against oxidative stress injury via Nrf2 protein accumulation.

Authors:  Ana Cristina Andérica-Romero; Jacqueline Hernández-Damián; Gustavo Ignacio Vázquez-Cervantes; Ismael Torres; José Pedraza-Chaverri
Journal:  Redox Biol       Date:  2016-03-02       Impact factor: 11.799

3.  Prevention of Streptozotocin-Induced Diabetic Nephropathy by MG132: Possible Roles of Nrf2 and IκB.

Authors:  Lili Kong; Yangwei Wang; Manyu Luo; Yi Tan; Wenpeng Cui; Lining Miao
Journal:  Oxid Med Cell Longev       Date:  2017-03-08       Impact factor: 6.543

4.  Stress Resistance Screen in a Human Primary Cell Line Identifies Small Molecules That Affect Aging Pathways and Extend Caenorhabditis elegans' Lifespan.

Authors:  Peichuan Zhang; Yuying Zhai; James Cregg; Kenny Kean-Hooi Ang; Michelle Arkin; Cynthia Kenyon
Journal:  G3 (Bethesda)       Date:  2020-02-06       Impact factor: 3.154

5.  IκB kinase promotes Nrf2 ubiquitination and degradation by phosphorylating cylindromatosis, aggravating oxidative stress injury in obesity-related nephropathy.

Authors:  Yin-Yin Chen; Han Hong; Yu-Ting Lei; Jia Zou; Yi-Ya Yang; Li-Yu He
Journal:  Mol Med       Date:  2021-10-28       Impact factor: 6.354

Review 6.  Friend or Foe: Xenobiotic Activation of Nrf2 in Disease Control and Cardioprotection.

Authors:  William D Hedrich; Hongbing Wang
Journal:  Pharm Res       Date:  2021-02-22       Impact factor: 4.200

Review 7.  Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury.

Authors:  Wenpeng Cui; Yang Bai; Ping Luo; Lining Miao; Lu Cai
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

Review 8.  The role of ubiquitination and sumoylation in diabetic nephropathy.

Authors:  Chenlin Gao; Wei Huang; Keizo Kanasaki; Yong Xu
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

Review 9.  The role of Nrf2-mediated pathway in cardiac remodeling and heart failure.

Authors:  Shanshan Zhou; Wanqing Sun; Zhiguo Zhang; Yang Zheng
Journal:  Oxid Med Cell Longev       Date:  2014-07-01       Impact factor: 6.543

10.  TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy.

Authors:  Kautilya Kumar Jena; Srinivasa Prasad Kolapalli; Subhash Mehto; Parej Nath; Biswajit Das; Pradyumna Kumar Sahoo; Abdul Ahad; Gulam Hussain Syed; Sunil K Raghav; Shantibhusan Senapati; Swati Chauhan; Santosh Chauhan
Journal:  EMBO J       Date:  2018-08-24       Impact factor: 11.598
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.